SilverCrest Metals
SILV
Cars.com
CARS
Collegium Pharmaceutical
COLL
Halozyme Therapeutics
HALO
Lantheus
LNTH
US Stock MarketDetailed Quotes
MRNA Moderna
- 40.450
- +0.180+0.45%
Trading Dec 26 15:26 ET
15.57BMarket Cap-6.96P/E (TTM)
40.490High39.240Low2.99MVolume39.550Open40.270Pre Close119.50MTurnover0.86%Turnover RatioLossP/E (Static)384.82MShares170.47052wk High1.31P/B14.04BFloat Cap35.80052wk Low--Dividend TTM347.11MShs Float497.490Historical High--Div YieldTTM3.10%Amplitude11.540Historical Low40.022Avg Price1Lot Size
Moderna Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 2.13%-1.57B | -39.23%-1.27B | 19.27%-989M | -162.60%-3.12B | -62.58%622M | -734.92%-1.6B | -400.99%-915M | -144.34%-1.23B | -63.43%4.98B | -49.79%1.66B |
| Net income from continuing operations | 100.36%13M | 7.32%-1.28B | -1,587.34%-1.18B | -156.37%-4.71B | -85.19%217M | -448.03%-3.63B | -162.81%-1.38B | -97.84%79M | -31.47%8.36B | -69.91%1.47B |
| Operating gains losses | -75.76%8M | 162.86%22M | -27.78%13M | --35M | --19M | --33M | ---35M | --18M | ---- | ---- |
| Depreciation and amortization | -79.12%52M | -55.43%41M | -53.85%36M | 78.45%621M | 152.50%202M | 120.35%249M | 21.05%92M | -1.27%78M | 50.00%348M | 2.56%80M |
| Deferred tax | --0 | --0 | --0 | 248.12%828M | -23.26%-106M | 1,609.28%1.46B | 4.35%-220M | -112.33%-310M | -75.79%-559M | ---86M |
| Other non cash items | -102.70%-1M | 150.00%4M | 175.00%3M | -75.00%7M | -125.00%-18M | 76.19%37M | ---8M | ---4M | --28M | ---8M |
| Change In working capital | -1,050.00%-1.73B | -125.44%-146M | 105.24%60M | 95.98%-139M | 62.75%249M | 120.13%182M | 131.63%574M | -28.68%-1.14B | -364.14%-3.46B | 111.12%153M |
| -Change in receivables | 14.26%-1.4B | -102.95%-26M | 177.57%755M | -72.46%493M | -25.65%974M | -40,750.00%-1.63B | 82.40%881M | 27,100.00%272M | 200.34%1.79B | 4,069.70%1.31B |
| -Change in inventory | -104.82%-11M | -677.78%-104M | -143.06%-93M | 51.83%747M | -74.73%285M | 246.15%228M | -14.29%18M | 143.11%216M | 135.29%492M | 336.97%1.13B |
| -Change in prepaid assets | -116.41%-150M | --0 | 101.42%3M | 157.33%974M | 119.61%202M | 364.93%914M | -22.22%70M | 48.79%-212M | -247.44%-1.7B | -239.93%-1.03B |
| -Change in payables and accrued expense | -83.82%143M | 96.92%-7M | -19.87%-712M | -1,400.00%-312M | -195.91%-375M | 1,093.26%884M | 78.84%-227M | -174.72%-594M | -98.84%24M | -55.47%391M |
| -Change in other current assets | 99.85%-1M | -500.00%-78M | 300.00%16M | -2,980.95%-605M | 750.00%52M | -7,300.00%-648M | -230.00%-13M | -60.00%4M | 136.21%21M | 75.76%-8M |
| -Change in other current liabilities | -97.78%14M | -2,300.00%-110M | 1,227.27%124M | 743.24%624M | 98.84%-2M | 31,500.00%632M | -97.72%5M | -144.00%-11M | -47.14%74M | -257.80%-172M |
| -Change in other working capital | -66.49%-323M | 211.88%179M | 95.97%-33M | 50.45%-2.06B | 39.50%-887M | 39.56%-194M | 89.78%-160M | -1.74%-819M | -247.20%-4.16B | 3.43%-1.47B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 2.13%-1.57B | -39.23%-1.27B | 19.27%-989M | -162.60%-3.12B | -62.58%622M | -734.92%-1.6B | -400.99%-915M | -144.34%-1.23B | -63.43%4.98B | -49.79%1.66B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -8.62%721M | -15.17%1.65B | -94.13%118M | 181.26%4.21B | 48.66%-538M | -16.51%789M | 268.75%1.94B | 151.29%2.01B | 39.27%-5.18B | 7.91%-1.05B |
| Net PPE purchase and sale | -7.86%-151M | 22.22%-182M | -73.45%-196M | -76.75%-707M | -139.13%-220M | -57.30%-140M | -168.97%-234M | 14.39%-113M | -40.85%-400M | 23.33%-92M |
| Net business purchase and sale | --0 | --0 | --0 | ---85M | --0 | --0 | --0 | ---85M | --0 | --0 |
| Net investment purchase and sale | -6.14%872M | -15.93%1.83B | -85.79%314M | 206.02%5.02B | 67.79%-295M | -10.15%929M | 304.51%2.18B | 158.30%2.21B | 42.31%-4.74B | 7.29%-916M |
| Net other investing changes | ---- | ---- | ---- | 42.50%-23M | ---- | ---- | ---- | ---- | -33.33%-40M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -8.62%721M | -15.17%1.65B | -94.13%118M | 181.26%4.21B | 48.66%-538M | -16.51%789M | 268.75%1.94B | 151.29%2.01B | 39.27%-5.18B | 7.91%-1.05B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 118.97%11M | 105.09%34M | 102.58%14M | 60.06%-1.38B | 75.11%-109M | 94.43%-58M | 49.66%-668M | 15.58%-542M | -294.96%-3.45B | 49.83%-438M |
| Net issuance payments of debt | 104.62%3M | 103.57%2M | 96.00%-1M | -46.74%-270M | -103.28%-124M | -41.30%-65M | -21.74%-56M | 19.35%-25M | -31.43%-184M | -38.64%-61M |
| Net common stock issuance | 14.29%8M | 105.23%32M | 102.90%15M | 66.08%-1.11B | 103.98%15M | 100.70%7M | 52.22%-612M | 15.38%-517M | -345.29%-3.26B | 54.52%-377M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 118.97%11M | 105.09%34M | 102.58%14M | 60.06%-1.38B | 75.11%-109M | 94.43%-58M | 49.66%-668M | 15.58%-542M | -294.96%-3.45B | 49.83%-438M |
| Net cash flow | ||||||||||
| Beginning cash position | -35.11%2.48B | -40.16%2.07B | -8.98%2.93B | -53.10%3.22B | -2.89%2.95B | 32.48%3.82B | -31.60%3.46B | -53.10%3.22B | 160.24%6.86B | -45.32%3.04B |
| Current changes in cash | 4.14%-833M | 13.30%409M | -451.23%-857M | 92.07%-289M | -114.20%-25M | -657.05%-869M | 116.60%361M | 113.56%244M | -186.25%-3.64B | -86.45%176M |
| End cash Position | -44.23%1.65B | -35.11%2.48B | -40.16%2.07B | -8.98%2.93B | -8.98%2.93B | -2.89%2.95B | 32.48%3.82B | -31.60%3.46B | -53.10%3.22B | -53.10%3.22B |
| Free cash flow | 1.32%-1.72B | -26.72%-1.46B | 11.43%-1.19B | -183.50%-3.83B | -74.39%402M | -1,167.48%-1.74B | -629.49%-1.15B | -150.86%-1.34B | -65.65%4.58B | -50.78%1.57B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
